Glucotrol
Indicated to address type 2 diabetes mellitus to mitigate high blood sugar levels.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Minodiab
- Therapeutic class
Sulfonylurea
- Pharmacological class
Sulfonylurea
- Contraindications
type 1 diabetes; diabetic ketoacidosis; hypersensitivity
- Precautions and warnings
risk of hypoglycaemia; do not skip meals; use caution in hepatic impairment
- Minor side effects
nausea; diarrhoea
- Moderate side effects
hypoglycaemia; rash; dizziness
- Dosage forms
Tablet; Prolonged-release tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
30–60 minutes
- Duration
12–24 hours
- Storage instructions
Keep container tightly closed in a cool, dry place.
- Drug interactions
Alcohol; Beta blockers
- Age restrictions
Not for use in children.
Serious side effects
agranulocytosis — requires immediate medical attention; hepatitis — requires immediate medical attention
Patient summary
Indicated to address type 2 diabetes mellitus to mitigate high blood sugar levels.
Mechanism of action
This medication functions by stimulating pancreatic beta cells to produce more insulin, which assists in lowering blood glucose levels. It is primarily used when diet and exercise alone are insufficient.
Pregnancy and breastfeeding
Pregnancy: Use is generally avoided; insulin is preferred. Breastfeeding: Not recommended due to potential neonatal hypoglycaemia.
Glucotrol
Indicated to address type 2 diabetes mellitus to mitigate high blood sugar levels.
Editorial Notes
- Active ingredient(s): Glipizide
- Listed indication(s): Type 2 Diabetes Mellitus
Available option
- 240 tablets - 10 mg262-10-mg-3091